Rentschler Biopharma Overview
- Year Founded
-
1927
- Status
-
Private
- Employees
-
1,400
- Latest Deal Type
-
Debt
Rentschler Biopharma General Information
Description
Developer of stable and robust cell lines is designed to handle the outsourced manufacturing of drugs. The company's platform offers process development and manufacturing of biopharmaceuticals and related consulting activities, including project management and regulatory support, enabling businesses with quality management systems, a well-established operational excellence philosophy, and advanced technologies ensuring product quality and productivity at each development and manufacturing step.
Contact Information
Website
www.rentschler-biopharma.comCorporate Office
- Erwin-Rentschler-Strabe 21
- 88471 Laupheim
- Germany
Corporate Office
- Erwin-Rentschler-Strabe 21
- 88471 Laupheim
- Germany
Rentschler Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Debt - General | 01-Nov-2025 | Completed | Profitable | |||
| 2. Secondary Transaction - Private | Completed | Profitable | ||||
| 1. Later Stage VC (Series A) | 18-May-2016 | $1.6M | $1.6M | Completed | Profitable |
Rentschler Biopharma Comparisons
Industry
Financing
Details
Rentschler Biopharma Competitors (1)
One of Rentschler Biopharma’s competitors is Adragos Pharma, a Private Equity-Backed company based in Munich, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adragos Pharma | Private Equity-Backed | Munich, Germany |
Rentschler Biopharma Patents
Rentschler Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220313911-A1 | Device and method for closing syringe bodies | Active | 16-Sep-2019 | ||
| WO-2021052931-A1 | Device and method for closing syringe bodies | Inactive | 16-Sep-2019 | ||
| EP-2439276-A1 | Method for semi-synthetic production of extremely pure minicircle dna vectors from plasmids | Inactive | 05-Oct-2010 | ||
| CA-2813664-A1 | Methods for semi-synthetic production of high purity "minicircle" dna vectors from plasmids | Inactive | 05-Oct-2010 | ||
| AU-2011311637-A1 | Methods for semi-synthetically producing highly pure minicircle dna vectors from plasmids | Inactive | 05-Oct-2010 | C12N15/10 |
Rentschler Biopharma Signals
Rentschler Biopharma Investments (3)
Rentschler Biopharma’s most recent deal was a PE Growth/Expansion with Leukocare for . The deal was made on 23-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Leukocare | 23-Jun-2021 | PE Growth/Expansion | Other Pharmaceuticals and Biotechnology | ||
| Shire (Drug Manufacturing Facility in Milford) | 01-Apr-2019 | Corporate Asset Purchase | Buildings and Property | ||
| Leukocare | 02-Feb-2017 | Corporate | Other Pharmaceuticals and Biotechnology |
Rentschler Biopharma FAQs
-
When was Rentschler Biopharma founded?
Rentschler Biopharma was founded in 1927.
-
Where is Rentschler Biopharma headquartered?
Rentschler Biopharma is headquartered in Laupheim, Germany.
-
What is the size of Rentschler Biopharma?
Rentschler Biopharma has 1,400 total employees.
-
What industry is Rentschler Biopharma in?
Rentschler Biopharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Rentschler Biopharma a private or public company?
Rentschler Biopharma is a Private company.
-
What is Rentschler Biopharma’s current revenue?
The current revenue for Rentschler Biopharma is .
-
How much funding has Rentschler Biopharma raised over time?
Rentschler Biopharma has raised $1.6M.
-
Who are Rentschler Biopharma’s competitors?
Adragos Pharma is a competitor of Rentschler Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process